Fibronectin type III repeat based protein scaffolds with alternative binding surfaces

• US 10,571,472 B2
• Filed: 12/18/2017
• Issued: 02/25/2020
• Est. Priority Date: 09/27/2011
• Status: Active Grant

• Current Assignee: Janssen Biotech, Inc. (Johnson & Johnson)
• Original Assignee: Janssen Biotech, Inc. (Johnson & Johnson)
• Inventors: Diem, Michael, Jacobs, Steven
• Primary Examiner(s): Boesen, Christian C
• Application Number:
  US15/845,657
• Publication Number:
  US 20180143203A1
• Time in Patent Office: 799 Days
• Field of Search: None
• CPC Class Codes: C12N 15/1044 Preparation or screening of libraries displayed on scaffold proteins
• CPC Class Codes: C40B 30/04 by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
• CPC Class Codes: C40B 40/08 Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
• CPC Class Codes: C40B 40/10 Libraries containing peptides or polypeptides, or derivatives thereof
• CPC Class Codes: C40B 50/06 Biochemical methods, e.g. using enzymes or whole viable microorganisms
• CPC Class Codes: G01N 2333/78 Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
• CPC Class Codes: G01N 33/6845 Methods of identifying protein-protein interactions in protein mixtures

Abstract

Protein scaffolds and scaffold libraries based on a fibronectin type III (FN3) repeat with an alternative binding surface design, isolated nucleic acids encoding the protein scaffolds, vectors, host cells, and methods of making thereof are useful in the generation of therapeutic molecules and treatment and diagnosis of diseases and disorders.

Claims

1. A library of fibronectin module of type III (FN3) domains having a diversified C-CD-F-FG alternative surface formed by a C beta-strand, a CD loop, an F beta-strand, and an FG loop, comprising a reference FN3 domain polypeptide having the amino acid sequence at least 80% identical to that of SEQ ID NO:

27;

wherein the FN3 domains comprise at least one C beta-strand mutated residue and at least one F beta-strand mutated residue as compared to SEQ ID NO;

27,

wherein the at least one residue in the C beta-strand is mutated with the proviso that S30 is not mutated (residue numbering according to SEQ ID NO;

     27),

wherein the at least one residue in the F beta-strand is mutated with the proviso that E66 is not mutated (residue numbering according to SEQ ID NO;

     27),

wherein each of the C beta-strand residues L32, Q34 and Q36 are mutated (residue numbering according to SEQ ID NO;

     27) or each of the F-beta strand residues T68, S70 and Y72 are mutated (residue numbering according to SEQ ID NO;

     27).

2. The library of claim 1, wherein 1, 2, 3 or 4 residues in the CD loop residues of the FN3 domains are mutated with the proviso that G42 and E43 are not mutated (residues numbering according to SEQ ID NO:

27).

3. The library of claim 2, wherein the residues S38, E39, K40 and V41 in the CD loop are mutated.

4. The library of claim 1, wherein 1, 2, 3 or 4 residues in the FG loop are mutated with the proviso that the residues K75, G76, G77 and S80 are not mutated (residue numbering according to SEQ ID NO:

27).

5. The library of claim 4, wherein the residues H78, R79 and N81 in the FG loop are mutated (residue numbering according to SEQ ID NO:

27).